Thursday, September 28, 2023
Home > JNJ

JNJ Stock Up 3% in Pre-market as FDA Approves Johnson & Johnson Single-shot COVID-19 Vaccine

The vaccine developed by Johnson & Johnson has varying efficacies as shown by FDA documents. In the United States, efficiency is at 72%, 66% in Latin America, and about 64% in South Africa.The United States Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to the single-shot

Read More